Compatible ABO mismatch and liver transplantation: A single center's experience

Murat Aladag, Ahmet Gurakar, Cemalettin Camci, Ye Yong, Harlan Wright, Bakr Nour, Anthony Sebastian

Research output: Contribution to journalReview article

6 Citations (Scopus)

Abstract

Objectives: The current shortage of suitable donor organs and clinical urgency can lead to implanting grafts from ABO-mismatched donors. One-year graft survival rates for patients in this scenario have been reported as ranging between 25% and 75% less than those for ABO-identical or ABO-compatible grafts. We review and compare our experiences with transplanting ABO-identical and ABO-compatible mismatched livers. Materials and Methods: Considering orthotopic liver transplantation (OLTx), 520 were performed at our institution between November 1992 and May 2003, 55 of which were ABO-compatible mismatched transplants. We retrospectively reviewed the data and compared patient and graft survival rates. Results: Overall 1-month and 1-, 5-, and 10-year patient survival rates among identical (group 1) and mismatched (group 2) groups were 97% and 91%, 90%, and 88.5%, and 79%, and 74%, 66%, and 65%, respectively. No significant difference existed between the 2 groups (P > .05). Similarly, 1-month, and 1-, 5-, and 10-year graft survival rates among groups 1 and 2 were 96% and 87%, 89% and 83%, 78% and 71% and 66% and 59%, respectively; these were not significant either (P > .05). All of the patients in the mismatched group had a high status according to the United Network for Organ Sharing (UNOS). Only 1 person received an incompatible mismatched graft (B to A), which subsequently developed primary nonfunction. Conclusions: ABO-compatible mismatch OLTx is unavoidable given the current state of organ shortage. Our results suggest that this type of OLTx can be performed with minimal risk among patients who require urgent transplantation and have high rankings according to the UNOS and the model for end-stage liver disease (MELD) system.

Original languageEnglish
Pages (from-to)467-469
Number of pages3
JournalExperimental and Clinical Transplantation
Volume4
Issue number1
Publication statusPublished - Jun 2006
Externally publishedYes

Fingerprint

Liver Transplantation
Graft Survival
Survival Rate
Transplants
Tissue Donors
End Stage Liver Disease
Transplantation
Liver

Keywords

  • ABO-compatible mismatch
  • Incompatible mismatch
  • Orthotopic liver transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Aladag, M., Gurakar, A., Camci, C., Yong, Y., Wright, H., Nour, B., & Sebastian, A. (2006). Compatible ABO mismatch and liver transplantation: A single center's experience. Experimental and Clinical Transplantation, 4(1), 467-469.

Compatible ABO mismatch and liver transplantation : A single center's experience. / Aladag, Murat; Gurakar, Ahmet; Camci, Cemalettin; Yong, Ye; Wright, Harlan; Nour, Bakr; Sebastian, Anthony.

In: Experimental and Clinical Transplantation, Vol. 4, No. 1, 06.2006, p. 467-469.

Research output: Contribution to journalReview article

Aladag, M, Gurakar, A, Camci, C, Yong, Y, Wright, H, Nour, B & Sebastian, A 2006, 'Compatible ABO mismatch and liver transplantation: A single center's experience', Experimental and Clinical Transplantation, vol. 4, no. 1, pp. 467-469.
Aladag, Murat ; Gurakar, Ahmet ; Camci, Cemalettin ; Yong, Ye ; Wright, Harlan ; Nour, Bakr ; Sebastian, Anthony. / Compatible ABO mismatch and liver transplantation : A single center's experience. In: Experimental and Clinical Transplantation. 2006 ; Vol. 4, No. 1. pp. 467-469.
@article{6ce791fe203d403c8a37b5a84ad892ed,
title = "Compatible ABO mismatch and liver transplantation: A single center's experience",
abstract = "Objectives: The current shortage of suitable donor organs and clinical urgency can lead to implanting grafts from ABO-mismatched donors. One-year graft survival rates for patients in this scenario have been reported as ranging between 25{\%} and 75{\%} less than those for ABO-identical or ABO-compatible grafts. We review and compare our experiences with transplanting ABO-identical and ABO-compatible mismatched livers. Materials and Methods: Considering orthotopic liver transplantation (OLTx), 520 were performed at our institution between November 1992 and May 2003, 55 of which were ABO-compatible mismatched transplants. We retrospectively reviewed the data and compared patient and graft survival rates. Results: Overall 1-month and 1-, 5-, and 10-year patient survival rates among identical (group 1) and mismatched (group 2) groups were 97{\%} and 91{\%}, 90{\%}, and 88.5{\%}, and 79{\%}, and 74{\%}, 66{\%}, and 65{\%}, respectively. No significant difference existed between the 2 groups (P > .05). Similarly, 1-month, and 1-, 5-, and 10-year graft survival rates among groups 1 and 2 were 96{\%} and 87{\%}, 89{\%} and 83{\%}, 78{\%} and 71{\%} and 66{\%} and 59{\%}, respectively; these were not significant either (P > .05). All of the patients in the mismatched group had a high status according to the United Network for Organ Sharing (UNOS). Only 1 person received an incompatible mismatched graft (B to A), which subsequently developed primary nonfunction. Conclusions: ABO-compatible mismatch OLTx is unavoidable given the current state of organ shortage. Our results suggest that this type of OLTx can be performed with minimal risk among patients who require urgent transplantation and have high rankings according to the UNOS and the model for end-stage liver disease (MELD) system.",
keywords = "ABO-compatible mismatch, Incompatible mismatch, Orthotopic liver transplantation",
author = "Murat Aladag and Ahmet Gurakar and Cemalettin Camci and Ye Yong and Harlan Wright and Bakr Nour and Anthony Sebastian",
year = "2006",
month = "6",
language = "English",
volume = "4",
pages = "467--469",
journal = "Experimental and Clinical Transplantation",
issn = "1304-0855",
publisher = "Baskent University",
number = "1",

}

TY - JOUR

T1 - Compatible ABO mismatch and liver transplantation

T2 - A single center's experience

AU - Aladag, Murat

AU - Gurakar, Ahmet

AU - Camci, Cemalettin

AU - Yong, Ye

AU - Wright, Harlan

AU - Nour, Bakr

AU - Sebastian, Anthony

PY - 2006/6

Y1 - 2006/6

N2 - Objectives: The current shortage of suitable donor organs and clinical urgency can lead to implanting grafts from ABO-mismatched donors. One-year graft survival rates for patients in this scenario have been reported as ranging between 25% and 75% less than those for ABO-identical or ABO-compatible grafts. We review and compare our experiences with transplanting ABO-identical and ABO-compatible mismatched livers. Materials and Methods: Considering orthotopic liver transplantation (OLTx), 520 were performed at our institution between November 1992 and May 2003, 55 of which were ABO-compatible mismatched transplants. We retrospectively reviewed the data and compared patient and graft survival rates. Results: Overall 1-month and 1-, 5-, and 10-year patient survival rates among identical (group 1) and mismatched (group 2) groups were 97% and 91%, 90%, and 88.5%, and 79%, and 74%, 66%, and 65%, respectively. No significant difference existed between the 2 groups (P > .05). Similarly, 1-month, and 1-, 5-, and 10-year graft survival rates among groups 1 and 2 were 96% and 87%, 89% and 83%, 78% and 71% and 66% and 59%, respectively; these were not significant either (P > .05). All of the patients in the mismatched group had a high status according to the United Network for Organ Sharing (UNOS). Only 1 person received an incompatible mismatched graft (B to A), which subsequently developed primary nonfunction. Conclusions: ABO-compatible mismatch OLTx is unavoidable given the current state of organ shortage. Our results suggest that this type of OLTx can be performed with minimal risk among patients who require urgent transplantation and have high rankings according to the UNOS and the model for end-stage liver disease (MELD) system.

AB - Objectives: The current shortage of suitable donor organs and clinical urgency can lead to implanting grafts from ABO-mismatched donors. One-year graft survival rates for patients in this scenario have been reported as ranging between 25% and 75% less than those for ABO-identical or ABO-compatible grafts. We review and compare our experiences with transplanting ABO-identical and ABO-compatible mismatched livers. Materials and Methods: Considering orthotopic liver transplantation (OLTx), 520 were performed at our institution between November 1992 and May 2003, 55 of which were ABO-compatible mismatched transplants. We retrospectively reviewed the data and compared patient and graft survival rates. Results: Overall 1-month and 1-, 5-, and 10-year patient survival rates among identical (group 1) and mismatched (group 2) groups were 97% and 91%, 90%, and 88.5%, and 79%, and 74%, 66%, and 65%, respectively. No significant difference existed between the 2 groups (P > .05). Similarly, 1-month, and 1-, 5-, and 10-year graft survival rates among groups 1 and 2 were 96% and 87%, 89% and 83%, 78% and 71% and 66% and 59%, respectively; these were not significant either (P > .05). All of the patients in the mismatched group had a high status according to the United Network for Organ Sharing (UNOS). Only 1 person received an incompatible mismatched graft (B to A), which subsequently developed primary nonfunction. Conclusions: ABO-compatible mismatch OLTx is unavoidable given the current state of organ shortage. Our results suggest that this type of OLTx can be performed with minimal risk among patients who require urgent transplantation and have high rankings according to the UNOS and the model for end-stage liver disease (MELD) system.

KW - ABO-compatible mismatch

KW - Incompatible mismatch

KW - Orthotopic liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=33745626751&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745626751&partnerID=8YFLogxK

M3 - Review article

C2 - 16827645

AN - SCOPUS:33745626751

VL - 4

SP - 467

EP - 469

JO - Experimental and Clinical Transplantation

JF - Experimental and Clinical Transplantation

SN - 1304-0855

IS - 1

ER -